Peter Hammerer

1.3k citations
52 papers · 868 indexed · h-index 15

Peter Hammerer

50 papers receiving 840 citations

Peers

Peter Hammerer
Comparison fields: 5 of 92
  • Urology 140
  • Pulmonary and Respiratory Medicine 478
  • Endocrinology, Diabetes and Metabolism 129
  • Rheumatology 111
  • Cancer Research 108
Replace Hideyo Miyazaki with:
Hideyo Miyazaki Japan
Göran Ahlgren Sweden
Ignacio F. San Francisco Chile
David Grignon United States
Yasuyoshi Fujiuchi Japan
Francisco Pina Portugal
Shigehiko Koga Japan
Marie C. Hupe Germany
Jian Pan China
Teruaki Kumazawa Japan
Peter Hammerer relative to Hideyo Miyazaki Japan Hideyo Miyazaki's profile →
Citations per field
00.5×3.6×
Hideyo Miyazaki · 1×
Citations per year

Countries citing papers authored by Peter Hammerer

Since Specialization
Citations

This map shows the geographic impact of Peter Hammerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hammerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hammerer more than expected).

Fields of papers citing papers by Peter Hammerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hammerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hammerer. The network helps show where Peter Hammerer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Hammerer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Hammerer Line = papers co-authored together Peter Hammerer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20201
2 201917
3 20192
4 20192
5 20162
6 201522
7 2015117
8 201429
9 20109
10 201012
11 20093
12 200916
13 2008171
14 200652
15 20062
16 200635
17 200411
18 200168
19 20001
20 19991

About Peter Hammerer

Peter Hammerer is a scholar working on Pulmonary and Respiratory Medicine, Urology and Transplantation, having authored 52 papers that have together received 868 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (29 papers), Prostate Cancer Diagnosis and Treatment (20 papers), Bladder and Urothelial Cancer Treatments (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Hormonal and reproductive studies (6 papers), Urological Disorders and Treatments (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Urology (140 citations), Pulmonary and Respiratory Medicine (478 citations) and Endocrinology, Diabetes and Metabolism (129 citations). Peter Hammerer has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Antonio Alcaraz, Fritz H. Schröder, Ramiro Castro, Andrea Tubaro, Markus Graefen, Hartwig Huland, Andreas Erbersdobler, Ahmad Haider, Hendrik Isbarn and V. Ravery. Their work appears in journals such as European Urology, Journal of Clinical Oncology, The Journal of Urology, The Prostate and Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026